Global Fertility Clinics Market By Procedure (IVF with ICSI, IUI, IVF without ICSI, Surrogacy, and Other Procedures), By Treatment (Medications, Surgery, Intrauterine Insemination(IUI), and In Vitro Fertilization (IVF)), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Report Overview

Fertility Clinics Market size is expected to be worth around USD 95.40 Bn by 2032 from USD 33.0 Bn in 2022, growing at a CAGR of 11.2% during the forecast period from 2023 to 2032.

Request Covid - 19 Impact

Fertility clinics are clinics that help couples and sometimes individuals, who want to become parents however due to some medical reasons they are unable to attain this goal through natural sources. These clinics apply many diagnostic tests and sometimes very innovative medical treatments to realize conceptions and pregnancies. Fertility clinics are operated by trained professionals including sonographers, endocrinologists, and lab technicians. Fertility clinics look into both men and women for diagnosis of fertility complications. Different types of fertility clinics can offer very different patient experiences and levels of success. A fertility clinic connected with a hospital has advantages, which allow to development of experimental techniques.

Market Scope:

Procedure Analysis

The IVF with ICSI Segment to Witness Significant Growth

Based on procedure, the global fertility clinics market is segmented into IVF with ICSI, surrogacy IUI, IVF without ICSI, and others. The IVF with ICSI segment accounted for the largest market revenue share of 34% in 2022. Due to the product launches for IVF with ICSI technology, high success level, and increase in approval of IVF with ICSI by specialists for treating infertility diseases. IVF with ICSI yields fertilization results and helps reduce the problems with abnormal fertilization. It can also increase the chance of an egg becoming fertilized.

The surrogacy segment was dominating during the historical period and is estimated to hold the second largest market share. It gives the opportunity to the intended parents to know and form a special bond with their surrogate. It allows women who enjoy being pregnant to experience pregnancy.

By Treatment Analysis

The In-Vitro Fertilization (IVF) Segments Dominated the Global Fertility Clinics Market Growth

Based on treatment, the global fertility clinics market is divided into medications, surgery, intrauterine insemination(IUI), and In vitro fertilization(IVF). Among these, the In vitro fertilization (IVF)segment is anticipated for the highest market revenue share of 32% in 2022. Due to its high success rate. This process provides the best opportunity of having a child using their eggs. With IVF technological process ensures a baby with minimum risks. It removes most of the barriers which can prevent patients from considering women with blocked or damaged fallopian tubes. In vitro, fertilization provides significant opportunities by reducing the chances of miscarriage.

The intrauterine insemination (IUI) segment accounted for the second-largest market revenue share growth during the forecast period. It is less expensive compared to IVF and ICSI. This treatment does not require anesthesia. it also provides less stress on the body.

Key Market Segments:

By Procedure

• IVF with ICSI
• IUI
• IVF without ICSI
• Surrogacy
• Other Procedures

By Treatment

• Medications
• Surgery
• Intrauterine Insemination (IUI)
• In Vitro Fertilization(IVF)

Market Dynamics:

Drivers

Increasing Technological Advancements are the Major Factor Driving the Market Growth

Rising technological advancements in fertility treatments, increasing success rates with IVF-ICSI in cases of low sperm count in men, and increasing availability of healthcare facilities are the major factors driving the market growth. The development of fertility clinics and services is expected to propel by expansion in assisted reproductive technology and a rise in the number of fertility clinics. The growth of the market is mainly driven by the rise in the prevalence of infertility in the male and female population and the increase in fertility disorders.

Fertility clinics can provide wonderful results for patients. Smaller clinics are often able to provide more handholding and personalized care, while larger clinics may offer better resources. R&D is continuously increasing in the healthcare industry for infertility treatment which is estimated to drive market growth. The ongoing smart healthcare product, technological developments, and innovation of new tools boost the market growth.

Restraints

Excessive Cost of Fertility Services Hinder the Market Growth

Extreme costs of fertility services such as surrogacy, in vitro fertilization(IVF), and artificial insemination are estimated to hamper market growth. Lack of awareness regarding male infertility is attributed to having a negative impact on the growth of the fertility clinics market. increasing inadequate reimbursement policies will hinder market growth.

Opportunity

Advancements in Reproductive Medicine Created Lucrative Opportunities in the Market

Helping couples with identifying fertility problems, and finding a solution to achieve their goals of creating a family is a lucrative opportunity in the market. An embryologist plays a crucial role by providing a number of tests in fertility clinics and helping individuals to fulfill the dream of being a parent. With the advancements in reproductive medicine, more fertility clinics are developing which propel the market growth. Developments in healthcare infrastructure, with increasing medical tourism because of low costs treatments are major factors providing growth opportunities for the market.

Trends

Novel Treatment Options are the Global Trend in the Market

Novel treatment options for women to increase fertility preservation are the global trend in the market. Fertility solutions are becoming more standard for many modern families. The upcoming fertility clinic treatments will remain to include the needs of couples. Novel technologies optimize clinical care and enhance clinic operations can fuel the field and support more patients in achieving successful outcomes.

COVID-19 Impact Analysis

COVID-19 Pandemic Impact on the Market

The COVID-19 pandemic had a significant impact on the market. The outbreak of COVID-19 has affected most of the world’s major markets, with no exception being the fertility clinic market. Although, there is no information available about the particular effects of COVID-19 on abortion and fertility. COVID-19 is determining the situation and most companies are beginning their facilities at maximum capacity. Due to the outbreak of COVID-19, many fertility treatments were suspended across the globe.

Regional Analysis

North America Region Accounted for the Significant Share of the Global Fertility Clinics Market

North America accounted for a significant global fertility clinics market share of revenue at 35.3% during the forecast period, Due to the increase in the prevalence of infertility and the upsurge in the number of product launches for fertility clinics. Various non-profit healthcare organizations and an increasing number of campaigns initiated by government drive the regional growth. Additionally, the well-developed healthcare infrastructure in North American countries is the major factor that propels the increase in the target audience. The Asia-Pacific is expected to grow maximum revenue share during the forecast period. Due to the increasing prevalence of chronic diseases and obesity.

Key Regions

North America

• US
• Canada
• Mexico

Western Europe

• Germany
• France
• The UK
• Spain
• Italy
• Portugal
• Ireland
• Austria
• Switzerland
• Benelux
• Nordic
• Rest of Western Europe

Eastern Europe

• Russia
• Poland
• The Czech Republic
• Greece
• Rest of Eastern Europe

APAC

• China
• Japan
• South Korea
• India
• Australia & New Zealand
• Indonesia
• Malaysia
• Philippines
• Singapore
• Thailand
• Vietnam
• Rest of APAC

Latin America

• Brazil
• Colombia
• Chile
• Argentina
• Costa Rica
• Rest of Latin America

Middle East & Africa

• Algeria
• Egypt
• Israel
• Kuwait
• Nigeria
• Saudi Arabia
• South Africa
• Turkey
• United Arab Emirates
• Rest of MEA

Recent Development

1. May 2021- Virtus Health, a global leader in Assisted Reproductive Services announced a strategic partnership with Drop Bio, a company focused on chronic inflammation, to propel further developments to deliver accurate fertility.
2. March 2022- Alife Health acknowledged a million investment. With its goal to generate an operative system for the next generation of IVF care delivery, the AI-led brand has transitioned from its R&D phase into initial traction and commercialization.

The following are some of the major players:

• Merck & Co, Inc.
• Berlex Laboratories Inc.
• Novartis AG
• Bayer AG
• Zydus Pharmaceuticals, Inc.
• Care Fertility Group Ltd
• Genea Limited
• Medicover AB
• Monash IVF Group
• Carolinas Fertility Institute
• Other Key Players

Report Scope: